USDA research showed higher carbohydrate and balanced fat intake can prevent certain diseases
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
NIH awarded contracts worth $228 million to develop innovative digital health technologies for COVID-19
On Sept. 15, 2020, the NIH awarded seven contracts worth a total of $22.8 million to companies and…
FDA contracted with global partners to analyze coronavirus samples
On Sept. 15, 2020, the FDA awarded a $5.4 million research contract to the University of Liverpool and…
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Life Science History | Medical Device
FDA published comparative performance data for COVID-19 molecular diagnostic tests
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The…
Vaxess Technologies to develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
Thermo Fisher Scientific further expanded laboratory plastics production to support COVID-19 testing, therapies and vaccines
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of India
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India. With…
Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
On Sept. 15, 2020, Soligenix announced publication of nonclinical results characterizing filovirus protein antigens (including for Ebola and…
Tonix Pharma enrolled first patient in COV-LOGIC study to assess antibody and T cell responses to SARS-CoV-2
On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…
OPKO Health initiated clinical trial of RAYALDEE in COVID-19 patients
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEï¾® as a…
BioNTech received ï¾€375M in funding from German Federal Ministry to support COVID-19 vaccine program BNT162
On Sept. 15, 2020, BioNTech announced that had receive a grant of up to 375 million Euro from…
Factors inherent to obesity could increase vulnerability to COVID-19
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
Flu may increase the spread of Covid-19
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…
The US Dept of Defense awarded contracts for COVID-19 disposable isolation gowns
On Sept. 14, 2020, the U.S. Department of Defense, on behalf of the Department of Health and Human…
Valneva announced COVID-19 vaccine partnership with UK Government
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
Vaxart announced FDA clearance of IND application for oral COVID-19 vaccine
On Sept. 14, 2020, Vaxart announced that the FDA had completed its review of the Companyï¾’s Investigational New…
Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India
On Sept. 14, 2020, Mateon Therapeutics announced that its global study based on its ARTI-19 protocol for Artemisinin…
Valneva and Dynavax announced commercial supply agreement for inactivated, adjuvanted COVID-19 vaccine
On Sept. 14, 2020, Dynavax Technologies announced a commercial partnership for the supply of Dynavax’s CpG 1018 adjuvant…
Genomic leaders collaborated to create Australia’s first national COVID-19 tracking system
On Sept. 14, 2020, Illumina announced that the Australian public health laboratories will aim to sequence the virus…
Humanigen and Lonza announced collaboration to expand manufacturing of Humanigen’s COVID-19 therapeutic Candidate Lenzilumab
On Sept. 14, 2020, Humanigen and Lonza announced a strategic collaboration to expand the manufacturing capacity for lenzilumab…
Humanigen announced review of lenzilumab phase 3 study in COVID-19 by Data Safety Monitoring Board
On Sept. 14, 2020, Humanigen announced its Phase 3 registration trial of lenzilumab in patients with COVID-19 was…
Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
First hospitals in the world adopt Genesis Robotic Technology for cardiac heart rhythm disorders
On Sept. 14, 2020, Stereotaxis announced it had completed installations of the worldï¾’s first Genesis Robotic Magnetic Navigation…
RECOVERY COVID-19 phase 3 trial evaluated Regeneron’s REGN-COV2 investigational antibody cocktail in the UK
On Sept. 14, 2020, Regeneron and the University of Oxford announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY),…
Meridian launched novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva
On Sept. 14, 2020, Meridian Bioscience announced the launch of a novel highly sensitive SARS-CoV-2 antibody pair to…
Text analysis software track global biothreats, such as COVID-19
On Sept. 14, 2020, at the Pacific Northwest National Laboratory (PNNL) reported that U.S. analysts monitoring global biothreats…
Pascal Biosciences and SoRSE Technology announced partnership for cannabinoid drug development and cancer clinical trials
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
Gilead Sciences announced acquisition of Immunomedics for $21 billion
On Sept. 13, 2020, Gilead Sciences and Immunomedics announced an agreement whereby Gilead would acquire Immunomedics for $88.00…
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
On Sept. 12 2020, Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK…